Aarhus University Seal / Aarhus Universitets segl

Brian Stidsen Vandahl

Corporate Vice President, Recombinant Technologies, Global Research Technolgoies, Novo Nordisk A/S

Brian holds an MSc in Molecular Biology and has a PhD from Health, AU.

Brian has previously worked as a research scientist at Statens Serum Institut and Novo Nordisk A/S. 

Brian has a great deal of experience in the field of biotechnological research with a focus on development of protein-based pharmaceuticals.

He currently works as Corporate Vice President at Novo Nordisk A/S, where he is heading an organisation of approximately 120 people responsible for various aspects of recombinant technologies in research projects. The organisation is part of the Global Research Technologies area, which is responsible for the molecules investigated in Research at Novo Nordisk across all therapy areas.